Literature DB >> 2127428

The possible role of ionic species in selective biodistribution of photochemotherapeutic agents toward neoplastic tissue.

R Pottier1, J C Kennedy.   

Abstract

Photochemotherapeutic agents are photosensitizers that are selectively retained by neoplastic tissue. When tumor tissue containing these drugs is irradiated with visible electromagnetic radiation, the photosensitizing reaction may lead to tumor eradication, termed photodynamic therapy. Exogenous photosensitizers commonly used in clinical trials are mainly porphyrin derivatives. Phthalocyanines are currently being investigated as "second generation" photochemotherapeutic agents. The mechanism by which these photosensitizers are selectively retained in neoplastic tissue is unclear. This review examines the role of tissue and cellular pH as a factor in selective biodistribution. The pH values of normal and tumor tissue are summarized and the ionic species distribution diagram of porphyrins is presented. A two-fold mechanism of selective biodistribution is advanced, one involving normal tissue vs. tumor tissue selectivity, the other involving intracellular vs. intercellular distribution of sensitizer ionic species.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2127428     DOI: 10.1016/1011-1344(90)85183-w

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  13 in total

Review 1.  Photodynamic therapy in the treatment of cancer: current state of the art.

Authors:  R A Hsi; D I Rosenthal; E Glatstein
Journal:  Drugs       Date:  1999-05       Impact factor: 9.546

2.  Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2005-08-10       Impact factor: 3.631

Review 3.  A promising anticancer drug: a photosensitizer based on the porphyrin skeleton.

Authors:  Qizhi Zhang; Jun He; Wenmei Yu; Yanchun Li; Zhenhua Liu; Binning Zhou; Yunmei Liu
Journal:  RSC Med Chem       Date:  2020-02-25

4.  Photodynamic Therapy for Cancer and for Infections: What Is the Difference?

Authors:  Sulbha K Sharma; Pawel Mroz; Tianhong Dai; Ying-Ying Huang; Tyler G St Denis; Michael R Hamblin
Journal:  Isr J Chem       Date:  2012-09       Impact factor: 3.333

Review 5.  Molecular Sensing with Host Systems for Hyperpolarized 129Xe.

Authors:  Jabadurai Jayapaul; Leif Schröder
Journal:  Molecules       Date:  2020-10-11       Impact factor: 4.411

Review 6.  Photodynamic therapy.

Authors:  T J Dougherty; C J Gomer; B W Henderson; G Jori; D Kessel; M Korbelik; J Moan; Q Peng
Journal:  J Natl Cancer Inst       Date:  1998-06-17       Impact factor: 13.506

Review 7.  Current status of photodynamic therapy in oncology.

Authors:  R van Hillegersberg; W J Kort; J H Wilson
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

8.  Advance in photosensitizers and light delivery for photodynamic therapy.

Authors:  Il Yoon; Jia Zhu Li; Young Key Shim
Journal:  Clin Endosc       Date:  2013-01-31

9.  Synthesis, Structural Characterization, and Cytotoxic Activity of Novel Paramagnetic Platinum Hematoporphyrin IX Complexes: Potent Antitumor Agents.

Authors:  G Gencheva; D Tsekova; G Gochev; G Momekov; G Tyuliev; V Skumryev; M Karaivanova; P R Bontchev
Journal:  Met Based Drugs       Date:  2007

10.  The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy.

Authors:  L Lilge; M C Olivo; S W Schatz; J A MaGuire; M S Patterson; B C Wilson
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.